| GTO ID | GTC2087 |
| Trial ID | NCT03908671 |
| Disease | Lung Non-Small Cell Carcinoma | Esophageal Cancer |
| Therapy | mRNA vaccine |
| Treatment | Personalized mRNA Tumor Vaccine |
| Recruitment status | Recruiting |
| Title | Clinical Trial on the Safety and Efficacy of Neoantigen Antigen mRNA Tumor Vaccine in the Treatment of Advanced Esophageal Cancer and Non-small Cell Lung Cancer |
| Year | 2019 |
| Country | China |
| Company sponsor | Stemirna Therapeutics |
| Other ID(s) | STZD-1801 |
| Cohort 1 | |||||||
|
|||||||